CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This research is designed to determine if experimental treatment with PARP inhibitor, AZD5305, alone, or in combination with anti-cancer age....
Phase 1, Phase 2
Budapest, Hungary and 76 other locations
Primary Objective:* For Cohort A, Cohort B, and Cohort C Part 2: To assess the antitumor activity of tusamitamab ravtansine in metastatic breast cancer...
Phase 2
Budapest, Hungary and 28 other locations
liposome injection in combination with other approved drugs used for cancer therapy, namely 5 fluorouracil/leucovorin (5FU/LV) plus oxalipla ...
Phase 3
Budapest, Hungary and 199 other locations
Study to evaluate the efficacy, safety and tolerability of ponsegromab compared to placebo in patients with cancer, cachexia, and elevated G...
Phase 2
Budapest, Hungary and 77 other locations
Exon 14 skipping mutations, NSCLC harboring MET amplification, solid tumors harboring MET amplification, solid tumors harboring MET...
Phase 2
Budapest, Hungary and 90 other locations
The aim of this study is to compare Onivyde manufactured at two different production sites in adult participants with advanced cancer in the ...
Phase 1
Budapest, Hungary and 35 other locations
in participants with advanced pheochromocytoma/paraganglioma (PPGL), pancreatic neuroendocrine tumor (pNET), von Hippel-Lindau (VHL...
Phase 2
Budapest, Hungary and 75 other locations
Clinical trials
Research sites
Resources
Legal